HELIOS Klinikum Emil von Behring GmbH — Clinical Trial Site

41 Registered trials

17 Currently recruiting

Organisation

HELIOS Klinikum Emil von Behring GmbH

Location

Berlin, Germany

Identifier

ORG-100032142

Address

Walterhoeferstrasse 11, Zehlendorf, 14165, Germany

Departments

2611: Klinikum Emil von Behring
Clinic for Pneumology
Haus Q - Klinische Studien
Helios Klinikum Emil von Behring
HELIOS Klinikum Emil von Behring GmbH
Klinik f. Onkologie u. Hämatologie
Klinik für Hämatologie und Onkologie
Klinik für Interdisziplinäre Onkolo-gie
Klinik für Plastische und Ästhetische Chirurgie
Klinik für Pneumologie
Klinik für Pneumologie - Lungenklinik Heckeshorn
Klinik für Pneumologie (Haus Q)
Klinik für Pneumologie Lungenklinik Heckeshorn
Klinik für Pneumologie, Lungenklinik Heckeshorn
Lungenklinik Heckesborn
Lungenklinik Heckeshorn
Lungenklinik Heckeshorn, Klinik für Pneumologie
Lungenklink Heckshorn
n.a.
N/A
Pneumologie Onkologie u.Infektiologie
Pneumology

Clinical trials at this site (41)

Search interface

ANTELOPE – Atezolizumab/Carboplatin/nab-Paclitaxel vs. Pembrolizumab/Platinum/Pemetrexed in metastatic TTF-1 negative lung adenocarcinoma Ended

2023-505054-17-00 metastatic TTF-1 negative lung adenocarcinoma 6 2023-09-15
A clinical trial to compare the effectiveness of savolitinib plus osimertinib versus chemotherapy for the treatment of non-small cell lung c… Ended

2024-511169-12-00 Non-Small Cell Lung Cancer 5 2023-03-28
Pembrolizumab Monotherapy versus Sacituzumab Govitecan in Combination with MK‑3475 for PD-L1 TPS ≥50% Metastatic NSCLC Ended

2023-503501-11-00 Metastatic Non-small Cell Lung Cancer 5 2023-02-09
A study of lurbinectedin in combination with atezolizumab compared with atezolizumab as maintenance therapy in participants with extensive-s… Ended

2023-503868-16-00 Small-Cell Lung Cancer (SCLC) 5 2022-02-14
A Study to Compare the Efficacy and Safety of Entrectinib and Crizotinib in Participants With Advanced or Metastatic ROS1 Non-small Cell Lun… Ended

2023-507494-18-00 Non-small cell lung cancer with ROS proto-oncogene 1, r 5 2021-09-24
A Clinical Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib Versus Lazertinib as First-Line Treatment in Patients … Ended

2023-506576-27-00 EGFR-mutated locally advanced or metastatic Non Small C 5 2020-09-30
ABP - Advancing Brigatinib Properties in anaplastic lymphoma kinase positive nonsmall cell lung cancer (ALK+ NSCLC) patients by deep phenoty… Ended

2024-513947-94-00 locally advanced (stage III) and not suitable for curat 4 2020-03-30
Short course radiotherapy versus chemoradiotherapy, followed by consolidation chemotherapy, and selective organ preservation for MRI-defined… Ended

2024-511577-29-01 intermediate and high-risk rectal cancer 5 2020-03-13
Chemo +/- Pembrolizumab (MK-3475) as Perioperative Therapy for Stage II, IIIA-Resectable IIIB (N2) NSCLC Ended

2023-504820-24-00 Neoadjuvant/Adjuvant treatment for participants with Re 5 2018-03-21
A global study of volrustomig (MEDI5752) plus chemotherapy versus pembrolizumab plus chemotherapy for participants with metastatic non-small… Halted

2023-503298-39-00 Metastatic Non-Small Cell Lung Cancer (mNSCLC) 5 2024-06-13
A study to Assess the Efficacy and Safety of Namilumab in subjects with lung inflammatory disease Ended

2024-511115-25-00 chronic pulmonary sarcoidosis 4 2022-11-21
Study to investigate the efficacy and safety of allo-APZ2-CVU on wound healing of therapy-resistant chronic venous ulcer (CVU) Ended

2023-510162-27-00 Chronic venous ulcers (CVU) 4 2021-08-18
MK-7684A (new drug co-formulation of pembrolizumab with an anti-TIGIT) plus docetaxel works to help stop or slow down the growth of your non… Ended

2022-501252-28-00 Non Small Cell Lung cancer 4 2021-04-15
A Study of Tiragolumab in Combination with Atezolizumab Plus Pemetrexed and Carboplatin/Cisplatin versus Pembrolizumab Plus Pemetrexed and C… Ended

2022-502031-20-00 Non-squamous non-small cell lung cancer (NSCLC) 10 2020-12-17
A study of nivolumab and ipilimumab in untreated patients with stage 3 NSCLC that is unable or not planned to be removed by surgery Ended

2022-502886-71-00 Previously Untreated Locally Advanced Non-small Cell Lu 5 2019-11-20
A Study of Nivolumab and Ipilimumab Combined with Chemotherapy Compared to Chemotherapy by Itself as the First Treatment Given for Stage IV … Ended

2023-508757-75-00 Stage IV Non-Small Cell Lung Cancer (NSCLC) 5 2017-09-18
Pembrolizumab in Combination With Axitinib Versus Sunitinib Monotherapy in Participants With Renal Cell Carcinoma Ended

2023-507294-18-00 Metastatic renal cell carcinoma 5 2016-09-16